Sign Up Today and Learn More About Cerevast Therapeutics Stock

Invest in or calculate the value of your shares in Cerevast Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

Cerevast Therapeutics Stock

Cerevast Therapeutics is a medical technology company developing treatments for acute ischemic stroke and other vascular disorders.

About Cerevast Therapeutics Stock

Founded

2009

Headquarters

Redmond, WA, US

Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. This non-invasive treatment is administered with Cerevast’s proprietary ultrasonic headframe called the ClotBust-ERTM, an operator independent device that can be rapidly and easily deployed by virtually any emergency room staff to safely administer the ultrasound energy for SonoLysis therapy. Cerevast was formed in September of 2009 following the acquisition of substantially all of the assets of ImaRx Therapeutics, Inc. – a publicly traded company focused on the development of microsphere contrast agents and therapeutics. Through this acquisition, Cerevast gained title to the dominant intellectual property estate and an extensive data package of pre-clinical and clinical studies. Cerevast has assembled a management team with extensive technical, scientific, commercial and regulatory expertise. The company has also assembled a Scientific Advisory Board comprised of globally recognized clinicians, all of whom are leading experts in the field of SonoLysis, ultrasound development and stroke treatment. The company’s headquarters are located in Redmond, Washington.

Cerevast Therapeutics Press Mentions

Stay in the know about the latest news on Cerevast Therapeutics

Cerevast Therapeutics Management

Leadership team at Cerevast Therapeutics

CTO

Francesco Curra

Chief Financial Officer

Kendall Stever

Locked Features

Join now and verify your accreditation status to gain access to:

  • Cerevast Therapeutics current valuation
  • Cerevast Therapeutics stock price
  • Available deals in Cerevast Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Cerevast Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like Cerevast Therapeutics through EquityZen funds. These investments are made available by existing Cerevast Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Cerevast Therapeutics stock?

Shareholders can sell their Cerevast Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."